118 related articles for article (PubMed ID: 3943493)
1. Intracerebroventricular infusion of aldosterone induces hypertension in rats.
Gomez-Sanchez EP
Endocrinology; 1986 Feb; 118(2):819-23. PubMed ID: 3943493
[TBL] [Abstract][Full Text] [Related]
2. Intracerebroventricular infusion of RU28318 blocks aldosterone-salt hypertension.
Gómez-Sánchez EP; Fort CM; Gómez-Sánchez CE
Am J Physiol; 1990 Mar; 258(3 Pt 1):E482-4. PubMed ID: 2316642
[TBL] [Abstract][Full Text] [Related]
3. Dose-response studies of intracerebroventricular infusion of aldosterone in sensitized and non-sensitized rats.
Gomez Sanchez EP
J Hypertens; 1988 Jun; 6(6):437-42. PubMed ID: 3411122
[TBL] [Abstract][Full Text] [Related]
4. ICV infusion of corticosterone antagonizes ICV-aldosterone hypertension.
Gómez-Sánchez EP; Venkataraman MT; Thwaites D; Fort C
Am J Physiol; 1990 Apr; 258(4 Pt 1):E649-53. PubMed ID: 2333961
[TBL] [Abstract][Full Text] [Related]
5. Differential central effects of mineralocorticoid and glucocorticoid agonists and antagonists on blood pressure.
van den Berg DT; de Kloet ER; van Dijken HH; de Jong W
Endocrinology; 1990 Jan; 126(1):118-24. PubMed ID: 2293978
[TBL] [Abstract][Full Text] [Related]
6. Effect of central amiloride infusion on mineralocorticoid hypertension.
Gomez-Sanchez EP; Gomez-Sanchez CE
Am J Physiol; 1994 Nov; 267(5 Pt 1):E754-8. PubMed ID: 7977727
[TBL] [Abstract][Full Text] [Related]
7. Relative inhibitory potency of five mineralocorticoid antagonists on aldosterone biosynthesis in vitro.
Netchitailo P; Delarue C; Perroteau I; Leboulenger F; Capron MH; Vaudry H
Biochem Pharmacol; 1985 Jan; 34(2):189-94. PubMed ID: 2981534
[TBL] [Abstract][Full Text] [Related]
8. What is the role of the central nervous system in mineralocorticoid hypertension?
Gómez Sánchez EP
Am J Hypertens; 1991 Apr; 4(4 Pt 1):374-81. PubMed ID: 1647798
[TBL] [Abstract][Full Text] [Related]
9. Effects of antimineralocorticoid RU 26752 on steroid-induced hypertension in rats.
Kalimi M; Opoku J; Agarwal M; Corley K
Am J Physiol; 1990 May; 258(5 Pt 1):E737-9. PubMed ID: 2333987
[TBL] [Abstract][Full Text] [Related]
10. Detection and comparative evaluation of aldosterone antagonists in glucocorticoid-treated, adrenalectomized rats.
Casals-Stenzel J; Buse M; Losert W
Eur J Pharmacol; 1982 May; 80(1):37-45. PubMed ID: 7095004
[TBL] [Abstract][Full Text] [Related]
11. Effect of a new mineralocorticoid antagonist mespirenone on aldosterone-induced hypertension.
Opoku J; Kalimi M; Agarwal M; Qureshi D
Am J Physiol; 1991 Feb; 260(2 Pt 1):E269-71. PubMed ID: 1996630
[TBL] [Abstract][Full Text] [Related]
12. Mechanism of action of a new antialdosterone compound, prorenone.
Claire M; Rafestin-Oblin ME; Michaud A; Roth-Meyer C; Corvol P
Endocrinology; 1979 Apr; 104(4):1194-200. PubMed ID: 436757
[TBL] [Abstract][Full Text] [Related]
13. Binding and antimineralocorticoid activities of spirolactones in toad bladder.
Rossier BC; Claire M; Rafestin-Oblin ME; Geering K; Gäggeler HP; Corvol P
Am J Physiol; 1983 Jan; 244(1):C24-31. PubMed ID: 6217754
[TBL] [Abstract][Full Text] [Related]
14. Central mineralocorticoid receptor antagonism blocks hypertension in Dahl S/JR rats.
Gomez-Sanchez EP; Fort C; Thwaites D
Am J Physiol; 1992 Jan; 262(1 Pt 1):E96-9. PubMed ID: 1310219
[TBL] [Abstract][Full Text] [Related]
15. A reevaluation of the mineralocorticoid and hypertensinogenic potential of 19-hydroxyandrostenedione.
Gomez-Sanchez EP; Gomez-Sanchez CE
Endocrinology; 1986 Jun; 118(6):2582-7. PubMed ID: 3698922
[TBL] [Abstract][Full Text] [Related]
16. Effects of intracerebroventricular infusion of aldosterone on blood pressure and sodium and potassium concentrations in cerebral spinal fluid in rats.
Atarashi K; Matsuoka H; Takagi M; Yamada K; Hirata Y; Hayakawa H; Sugimoto T
Clin Exp Hypertens A; 1988; 10 Suppl 1():317-22. PubMed ID: 3242997
[TBL] [Abstract][Full Text] [Related]
17. Experimental hypertension induced by 19-nor-progesterone treatment in the rat.
Komanicky P; Melby JC
Endocrinology; 1981 Oct; 109(4):1164-7. PubMed ID: 7285864
[TBL] [Abstract][Full Text] [Related]
18. Adrenocorticotrophin-induced hypertension: effects of mineralocorticoid and glucocorticoid receptor antagonism.
Li M; Wen C; Fraser T; Whitworth JA
J Hypertens; 1999 Mar; 17(3):419-26. PubMed ID: 10100081
[TBL] [Abstract][Full Text] [Related]
19. Lack of pressor response to intracerebroventricular infusion of aldosterone in sheep.
Tresham JJ; Coghlan JP; Whitworth JA; Scoggins BA
Clin Exp Pharmacol Physiol; 1990 May; 17(5):377-80. PubMed ID: 2354554
[TBL] [Abstract][Full Text] [Related]
20. Mespirenone and other 15,16-methylene-17-spirolactones, a new type of steroidal aldosterone antagonists.
Losert W; Bittler D; Buse M; Casals-Stenzel J; Haberey M; Laurent H; Nickisch K; Schillinger E; Wiechert R
Arzneimittelforschung; 1986 Nov; 36(11):1583-600. PubMed ID: 3028435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
